SphingoTec GmbH: Liberation From Renal Replacement Therapy and Early Initiation to Be Supported by The Kidney Function Biomarker Proenkephalin A 119-159
PenKid identified as a promising kidney function biomarker to support future precision medicine approaches for RRT-dependent AKI.A post-hoc analysis of the ELAIN trial indicates that penKid could enable
Deborah Bergmann Clin Biochem Pickkersp Proenkephalin Kostenloser Wertpapierhandel Sphingotec Gmbh Sphingotec Gmbhview
Source: finanznachrichten.de